Ado asx

AnteoTech Limited.

Market data is provided and copyrighted by Thomson Reuters and Morningstar. Click for restrictions. All rights reserved. ASX shareholders. Our Board.

Ado asx

July 11, James Mickleboro. May 18, Bernd Struben. May 18, Aaron Teboneras. March 23, Monica O'Shea. February 10, Alice de Bruin. The TGA has asked for more clinical data, so further trials will now be conducted. February 10, James Mickleboro. February 8, Mitchell Lawler. February 7, Monica O'Shea. February 1, Monica O'Shea.

Dividend Yield 0. Debt securities. The technology has various applications and also assists other diagnostic researchers in ado asx new products and medical devices.

AnteoTech Limited is an Australia-based surface chemistry company. The principal activities of the Company consist of research, development and commercialization of technologies with surface management applications. The activities are primarily focused on the commercialization of these technologies across applications in the Life Science and Clean Energy Technology markets. Its lead product, Anteo X, provides significant improvement in anode performance and the Company has partnered with global suppliers in lithium-ion battery manufacturing. The life sciences division services the point of care and diagnostics markets from global diagnostics companies to technology developers. Its AnteoBind provides advantages in bioconjugation to rapidly speed up testing procedures and improve accuracy.

Financial Times Close. Search the FT Search. Show more World link World. Show more US link US. Show more Companies link Companies. Show more Tech link Tech. Show more Markets link Markets. Show more Opinion link Opinion. Show more Personal Finance link Personal Finance.

Ado asx

Market data is provided and copyrighted by Thomson Reuters and Morningstar. Click for restrictions. All rights reserved. ASX shareholders. Our Board.

Hand drawn white heart png

January 31, James Mickleboro. Connectivity and data. Show more US link US. Starpharma Holdings Ltd. Year To Date Return Actions Add to watchlist Add to portfolio Add an alert. Open 0. Institutional shareholders Top holders Movers. High number of new and inexperienced directors Nov Corporate governance. All content on FT.

July 11, James Mickleboro. May 18, Bernd Struben.

During his tenure he was responsible for taking research from Sydney University through to product registration. Oct Today's Open. Inoviq Ltd. ASX Compliance. ASX regulatory framework. The activities are primarily focused on the commercialization of these technologies across applications in the Life Science and Clean Energy Technology markets. All rights reserved. The life sciences division services the point of care and diagnostics markets from global diagnostics companies to technology developers. Why list on ASX.